[Application of pegylated recombinant human granulocyte colony-stimulating factor to prevent chemotherapy-induced neutropenia in patients with lymphoma: a prospective, multicenter, open-label clinical trial].
Huang HQ, Bai B, Gao YH, Zou DH, Zou SH, Tan H, Song YP, Li ZY, Jin J, Li W, Su H, Gong YP, Zhong MZ, Shuang YR, Zhu J, Zhang JQ, Cai Z, Teng QL, Sun WJ, Yang Y, Xia ZJ, Chen HL, Hua LM, Bao YY, Wu N.
Huang HQ, et al. Among authors: sun wj.
Zhonghua Xue Ye Xue Za Zhi. 2017 Oct 14;38(10):825-830. doi: 10.3760/cma.j.issn.0253-2727.2017.10.001.
Zhonghua Xue Ye Xue Za Zhi. 2017.
PMID: 29166732
Free PMC article.
Clinical Trial.
Chinese.